Hybio Pharmaceutical Co., Ltd.
300199
株式のランク
#4739
Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical... Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical Co., Ltd. specializes in the global research, development, manufacturing, and commercialization of therapeutic peptide active pharmaceutical ingredients (APIs) and polypeptide medications. Its diverse product range addresses therapeutic needs such as diabetes (including liraglutide, semaglutide, and exenatide), gastrointestinal and metabolic disorders (with examples like terlipressin, desmopressin, and linaclotide), as well as applications in obstetrics and gynecology (featuring ganirelix, cetrorelix, and atosiban). Additionally, the company supplies custom peptides and provides essential working standards for peptide APIs and their impurities, offering comprehensive support for development initiatives. Beyond products, Hybio extends its expertise through Contract Research Organization (CRO) and an extensive Contract Development and Manufacturing Organization (CDMO) platform. This platform covers peptide API synthesis and purification process optimization, finished dosage form conceptualization, reference standard preparation and rigorous qualification, detailed impurity and product quality analysis, Good Manufacturing Practice (GMP) systems adhering to both EU and FDA benchmarks, and comprehensive regulatory and dossier support for both international and Chinese markets.
株価
$3.69
時価総額
$3.11B
変化（1日）
-7.75%
変化（1年）
21.56%
国
CN
取引 Hybio Pharmaceutical Co., Ltd. (300199)
カテゴリー
Healthcare
Hybio Pharmaceutical Co., Ltd.（300199）の株式分割履歴
Hybio Pharmaceutical Co., Ltd.株（シンボル：300199）は合計で3回の株式分割を実施しました。
最新の株式分割はApr 14, 2015に行われました。
May 17, 2012より前に購入された300199株は、現在8300199株に相当します。
最新の株式分割はApr 14, 2015に行われました。
May 17, 2012より前に購入された300199株は、現在8300199株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 2015-04-14 | 2:1 | x2 | x8 |
| 2013-04-26 | 2:1 | x2 | x4 |
| 2012-05-17 | 2:1 | x2 | x2 |
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 0 | - |
DE
|
|
| 2 | x2 |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
